{
  "agent": "memo-section-writer",
  "section_id": "L",
  "section_name": "Financial Risk Analysis and Purchase Price Adjustments",
  "status": "complete",

  "compaction_summary": {
    "task": "Write section IV.L (Financial Risk Analysis) from T9 financial-risk-aggregation-report",
    "progress": "ALL phases complete - section finalized",
    "next_action": "NONE - section complete and saved",
    "critical_context": [
      "section_id=L",
      "8 HIGH findings synthesized",
      "72 footnotes with verification tags",
      "14 draft contract provisions generated",
      "Board recommendation: PROCEED WITH CONDITIONS"
    ]
  },

  "phases_complete": {
    "phase_1_inputs": true,
    "phase_2_validation": true,
    "phase_3_structure": true,
    "phase_4_analysis": true,
    "phase_5_quality": true,
    "phase_6_finalize": true
  },

  "subsections_status": {
    "A_financial_risk_aggregation": "complete",
    "B_three_scenario_analysis": "complete",
    "C_purchase_price_adjustment": "complete",
    "D_escrow_structure": "complete",
    "E_risk_adjusted_valuation": "complete",
    "F_draft_provisions": "complete"
  },

  "recovery_instructions": {
    "on_compaction": "Section COMPLETE - no recovery needed. All subsections A-F written and finalized.",
    "do_not_repeat": [
      "A_financial_risk_aggregation",
      "B_three_scenario_analysis",
      "C_purchase_price_adjustment",
      "D_escrow_structure",
      "E_risk_adjusted_valuation",
      "F_draft_provisions"
    ],
    "do_not_reread_reports": [
      "specialist-reports/financial-risk-aggregation-report.md",
      "review-outputs/fact-registry.md",
      "review-outputs/risk-summary.json",
      "review-outputs/coverage-gaps.md"
    ]
  },

  "metrics": {
    "word_count": 8950,
    "findings_written": "8/8",
    "footnotes_count": 72,
    "high_severity_findings": 8,
    "draft_provisions_generated": 14,
    "cross_references": 47,
    "aggregate_gross_exposure": "$387.83M",
    "aggregate_weighted_exposure": "$71.96M",
    "net_base_case_exposure": "$13.48M",
    "last_checkpoint": "2026-01-26T00:00:00Z"
  },

  "input_files_read": [
    "specialist-reports/financial-risk-aggregation-report.md",
    "review-outputs/fact-registry.md",
    "review-outputs/risk-summary.json",
    "review-outputs/coverage-gaps.md"
  ],

  "output_file": "/Users/ej/Super-Legal/super-legal-mcp-refactored/reports/2026-01-26-1737849600/section-reports/section-IV-L-financial-risk-analysis.md",

  "quality_checks": {
    "subsections_complete": true,
    "statistics_table": true,
    "no_placeholders": true,
    "word_count_target_met": true,
    "all_high_findings_have_provisions": true,
    "citations_have_verification_tags": true,
    "counter_analysis_present": true,
    "no_advocacy_language": true
  },

  "board_recommendation": {
    "decision": "PROCEED WITH CONDITIONS",
    "mandatory_conditions": 5,
    "deal_blocking_conditions": [
      "Dr. Mitchell equity buyout refusal",
      "Seller insistence on stock purchase structure (loses $23.58M tax benefit)"
    ]
  }
}
